NYMOX PHARMACEUTICAL CORPORATION Current Assets
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) had Current Assets of $653.00 thousand as of 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2025-06-03
- 2024-12-31: Current Assets $653.00K.
- 2024-09-30: Current Assets $623.00K.
- 2023-12-31: Current Assets $625.00K.
- 2023-09-30: Current Assets $654.00K.
| Period end | Current Assets |
|---|---|
| 2024-12-31 | $653.00K 20-F · filed 2025-06-03 |
| 2024-09-30 | $623.00K 6-K · filed 2025-01-02 |
| 2023-12-31 | $625.00K 20-F · filed 2025-06-03 |
| 2023-09-30 | $654.00K 6-K · filed 2023-11-15 |
| 2023-06-30 | $214.00K 6-K · filed 2023-08-14 |
| 2023-03-31 | $461.00K 6-K · filed 2023-05-12 |
| 2022-12-31 | $1.46M 20-F · filed 2024-08-29 |
| 2022-09-30 | $2.91M 6-K/A · filed 2022-11-16 |
| 2022-06-30 | $4.18M 6-K · filed 2022-08-15 |
| 2022-03-31 | $890.00K 6-K · filed 2022-05-13 |
| 2021-12-31 | $1.04M 20-F · filed 2023-05-02 |
| 2021-09-30 | $3.39M 6-K · filed 2021-11-12 |
| 2021-06-30 | $6.33M 6-K · filed 2021-08-13 |
| 2021-03-31 | $1.06M 6-K · filed 2021-05-14 |
| 2020-12-31 | $3.89M 20-F · filed 2022-03-30 |
| 2020-09-30 | $5.63M 6-K · filed 2020-11-13 |
| 2020-06-30 | $886.00K 6-K · filed 2020-08-14 |
| 2020-03-31 | $3.13M 6-K · filed 2020-05-14 |
| 2019-12-31 | $5.33M 20-F · filed 2022-03-30 |
| 2019-09-30 | $7.22M 6-K · filed 2019-11-13 |
| 2019-06-30 | $9.20M 6-K · filed 2019-08-14 |
| 2019-03-31 | $11.49M 6-K · filed 2019-05-15 |
| 2018-12-31 | $8.03M 20-F · filed 2021-03-29 |
| 2018-09-30 | $4.75M 6-K · filed 2018-11-13 |
| 2018-06-30 | $5.15M 6-K · filed 2018-08-13 |
| 2018-03-31 | $936.00K 6-K · filed 2018-05-15 |
| 2017-12-31 | $961.00K 20-F · filed 2020-03-30 |
| 2016-12-31 | $2.04M 20-F · filed 2019-03-29 |
| 2015-12-31 | $692.00K 20-F · filed 2018-03-30 |